Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Clinical research and medical care: towards effective and complete integration.

Sacristán JA.

BMC Med Res Methodol. 2015 Jan 9;15:4. doi: 10.1186/1471-2288-15-4.

2.

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain ¿ a cost-effectiveness comparison.

Dilla T, Möller J, O Donohoe P, Alvarez M, Sacristán JA, Happich M, Tockhorn A.

BMC Psychiatry. 2014 Dec 2;14(1):298. [Epub ahead of print]

3.

Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients.

Sacristán JA.

BMC Med Inform Decis Mak. 2013 Jan 8;13:6. doi: 10.1186/1472-6947-13-6.

4.

Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.

Agúndez JA, Abad-Santos F, Aldea A, Alonso-Navarro H, Bernal ML, Borobia AM, Borrás E, Carballo M, Carvajal A, García-Muñiz JD, Gervasini G, Jiménez-Jiménez FJ, Lucena MI, Martínez C, Sacristán JA, Salado I, Sinués B, Vicente J, García-Martín E.

Front Genet. 2012 Nov 26;3:273. doi: 10.3389/fgene.2012.00273. eCollection 2012.

5.

Exploratory trials, confirmatory observations: a new reasoning model in the era of patient-centered medicine.

Sacristán JA.

BMC Med Res Methodol. 2011 Apr 25;11:57. doi: 10.1186/1471-2288-11-57.

6.

Health economics: the start of clinical freedom.

Sacristán JA, Costi M, Valladares A, Dilla T.

BMC Health Serv Res. 2010 Jun 28;10:183. doi: 10.1186/1472-6963-10-183.

7.

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population.

Asukai Y, Valladares A, Camps C, Wood E, Taipale K, Arellano J, Cassinello A, Sacristán JA, Dilla T.

BMC Cancer. 2010 Jan 29;10:26. doi: 10.1186/1471-2407-10-26.

8.

Serendipia: Castilla-La Mancha telepathology network.

Peces C, García-Rojo M, Sacristán J, Gallardo AJ, Rodríguez A.

Diagn Pathol. 2008 Jul 15;3 Suppl 1:S5. doi: 10.1186/1746-1596-3-S1-S5.

9.

Reading virtual slide using web viewers: results of subjective experience with three different solutions.

Rojo MG, Gallardo AJ, González L, Peces C, Murillo C, González J, Sacristán J.

Diagn Pathol. 2008 Jul 15;3 Suppl 1:S23. doi: 10.1186/1746-1596-3-S1-S23.

10.

Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia.

Reviriego J, Gomis R, Marañés JP, Ricart W, Hudson P, Sacristán JA.

Int J Clin Pract. 2008 Jul;62(7):1026-32. doi: 10.1111/j.1742-1241.2008.01783.x. Epub 2008 May 16.

12.

Problems and solutions in calculating quality-adjusted life years (QALYs).

Prieto L, Sacristán JA.

Health Qual Life Outcomes. 2003 Dec 19;1:80.

13.

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).

García-Cabeza I, Gómez JC, Sacristán JA, Edgell E, González de Chavez M.

BMC Psychiatry. 2001;1:7. Epub 2001 Dec 28.

14.

Bias in assignment to clinical trials.

Galende J, Soto J, Sacristán JA.

BMJ. 1994 Apr 2;308(6933):920-1. No abstract available.

15.

Monitoring theophylline treatment.

Sacristán JA, Chantal P, Soto J.

BMJ. 1993 Feb 13;306(6875):457. No abstract available.

16.

"Economic relevance" in pharmacoeconomic studies.

Sacristán JA, Hernández J, Soto J.

BMJ. 1993 Jan 9;306(6870):147. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk